The study introduces a novel "multi-route" administration protocol for Wharton’s Jelly-derived Mesenchymal Stem Cells (WJ-MSCs). Unlike previous trials that relied on a single delivery method, this ...

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does it mean for investors?

A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.

“The most important finding of our study was to establish that one intra-articular injection of ASC-EVs can profoundly affect the joint environment soon after administration.” The study, authored by ...

New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...

The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...

Stopping cancer cells from entering a soft biomechanical state could help the immune system clear dormant cancer metastasis.

Lipid imbalance triggered by Snail-driven epithelial–mesenchymal transition creates a cholesterol-dependent vulnerability that can be therapeutically targeted to overcome chemoresistance in cancer.